Immunoassay for intact amino-terminal propeptide of human type I procollagen

Clinical Chemistry

Volumn 42, Issue 6 SUPPL., 1996, Pages 947-954

  Melkko, Jukka ^a   Kauppila, Saila ^a   Nlemi, Seija ^b   Rlsteli, Leila ^a   Haukipuro, Kari ^a   Jukkola, Arja ^a   Risteli, Juha ^a  

^a UNIVERSITY OF OULU   (Finland)

^b Orion Diagnostica Oy   (Finland)

Author keywords

Bone; Cancer; Coll domain; Collagen; Pleural fluid

Indexed keywords

COLLAGEN TYPE 1; COLLAGENASE; POLYCLONAL ANTIBODY; PROCOLLAGEN; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER PATIENT; COLLAGEN SYNTHESIS; COLORECTAL CANCER; CONTROLLED STUDY; CROSS REACTION; FEMALE; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOASSAY; ION EXCHANGE CHROMATOGRAPHY; MALE; PLEURA FLUID; REVERSED PHASE LIQUID CHROMATOGRAPHY; SERUM; WOUND;

ADULT; AGED; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; COLLAGENASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PLEURAL EFFUSION; PROCOLLAGEN; RADIOIMMUNOASSAY; REFERENCE VALUES; WOUND HEALING;

EID: 0029938817     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.6.947     Document Type: Article

References (29)

1. Risteli L, Risteli J. Biochemical markers of bone metabolism. Ann Med 1993;25:385-93.
2. Birk DE, Zycband El, Winkelmann DA, Trelstad RL. Collagen fibrillogenesis in situ. Discontinuous segmental assembly in extracellular compartments. Ann N Y Acad Sci 1990;580:176-94.
3. Fleischmajer R, Perlish JS, Burgeson RE, Shaikh-Bahai F, Timpl R. Type I, type III collagen interactions during fibrillogenesis. Ann N Y Acad Sci 1990;580:161-75.
4. Fleischmajer R, Timpl R, Tuderman L, Raisher L, Wiestner M, Perlish JS, Graves PN. Ultrastructural identification of extension aminopropeptides of type I and III collagen in human skin. Proc Natl Acad Sci U S A 1981;78:7360-4.
5. Risteli L, Risteli J. Noninvasive methods for detection of organ fibrosis. In: Rojkind M, ed. Connective tissue in health and disease. Boca Raton, FL: CRC Press, 1990:61-98.
6. Melkko J, Hellevik T, Risteli L, Risteli J, Smedsrad B. The amino-terminal propeptide of type I procoliagen is a physiological ligand for the scavenger receptor of the endothelial cells of the liver. J Exp Med 1994;179:405-12.
7. Niemelä O, Risteli L, Sotaniemi EA, Risteli J. Heterogeneity of the antigens related to the amino-terminal propeptide of type III procoliagen in human serum. Clin Chim Acta 1982;124:39-44.
8. Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP, Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988;34: 715-8.
9. Jensen LT, Henriksen JH, Risteli J, Olesen HP, Nielsen MD, Lorenzen I. Fate of circulating amino-terminal propeptide of type III procollagen in conscious pigs. Am J Physiol 1993;265:R139-45.
10. Ebeling PR, Peterson JM, Riggs BL. Utility of type I procoliagen propeptide assays for assessing abnormalities in metabolic bone diseases. J Bone Miner Res 1992;7:1243-50.
11. Linkhart SG, Linkhart TA, Taylor AK, Wergedahl JE, Bettica P, Baylink DJ. Synthetic peptide-based immunoassay for aminoterminal propeptide of type I procollagen: application for evaluation of bone formation. Clin Chem 1993;39:2254-8.
12. Teisner B, Boje Rasmussen H, Højrup P, Yde-Andersen E, Skjødt K. Fetal antigen 2: an amniotic protein identified as the aminopropeptide of the al chain of human procoliagen type I. APMIS 1992;100:1106-14.
13. Price KM, Silman R, Armstrong P, Grudzinskas JG. Development of a radioimmunoassay for fetal antigen 2. Clin Chim Acta 1994; 224:95-102.
14. Jukkola A, Risteli L, Melkko J, Risteli J. Procollagen synthesis and extracellular matrix deposition in MG-63 osteosarcoma cells. J Bone Miner Res 1993;8:651-7.
15. Risteli J, Niemi S, Kauppila S, Melkko J, Risteli L. Collagen propeptides as indicators of collagen assembly. Acta Orthop Scand 1995;66(Suppl 266):183-8.
16. Hörlein D, Fietzek PP, Wachter E, Lapiere CM, Kühn K. Amino acid sequence of the amino-terminal segment of dermatosparactic calf-skin procollagen type I. Eur J Biochem 1979;99:31-8.
17. Risteli L, Risteli J. Analysis of extracellular matrix proteins in biological fluids. Methods Enzymol 1987;145:391-411.
18. Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990;36:1328-32.
19. Haukipuro K, Melkko J, Risteli L, Kairaluoma Ml, Risteli J. Synthesis of type I collagen in healing wounds in humans. Ann Surg 1991;213:75-80.
20. Tromp G, Kuivaniemi H, Stacey A, Shikata H, Baldwin CT, Jaenisch R, Prockop DJ. Structure of a full-tength cDNA clone for the preproα1(l) chain of human type I procoliagen. Biochem J 1988; 253:919-22.
21. Stein GS, Lian JB, Owen TA. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 1990;4:3111-23.
22. Risteli J, Risteli L. Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol 1995;22(Suppl. 2):77-81.
23. Rasmussen HB, Teisner B, Andersen JA, Brandrup F, Purkis T, Leigh I. Immunohistochemical studies on the localization of fetal antigen 2 (FA2), laminin, and collagen type 4 in basal cell carcinoma. J Cutan Pathol 1991;18:215-9.
24. Zhu G-G, Risteli L, Mäkinen M, Risteli J, Kauppila A, Stenbäck F. Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms. Cancer 1995;75:1010-7.
25. Eriksen EF, Brixen K, Charles P. New markers of bone metabolism; clinical use in metabolic bone disease. Eur J Endocrinol 1995;132:251-63.
26. Haapasaari KM, Risteli J, Koivukangas V, Oikarinen A. Comparison of the effect of hydrocortisohe, hydrocortisone-17-butyrate and betamethasone on collagen synthesis in human skin in vivo. Acta Derm Venereol (Stockh) 1995;75:269-71.
27. Risteli L, Suvanto-Luukkonen E, Sundstrodie;m H, Penttinen J, Kauppila A, Risteli J. Amino- and carboxyl-terminal propeptides of type I procollagen in serum during pots-menopausal estrogen-progesterone therapy. J Bone Min Res 1995;10(Suppl 1):S355.
28. Sharp CA, Evans SF, Risteli L, Risteli J, Worsfold M, Davie MWJ. Effects of low and conventional dose transcutaneous HRT over 2 years on bone metabolism in younger and older postmenopausal women. Eur J Clin Invest 1996; resubmitted after requested revision.
29. Sharp CA, Davie MWJ, Worsfold M, Risteli L, Risteli J. Discrepant blood concentrations of type I procollagen propeptides in active Paget disease of bone [Letter]. Clin Chem 1996;42:in press.